AdvertiseDonate
Tuesday, November 17, 2026
Today’s news, without the noise.
Breaking Blast · 230 S Broad St, 17th Floor, Philadelphia, PA 19102
News · Philadelphia

Researchers Find Higher Tau Levels in Advanced CTE Blood Samples

A preliminary study in JAMA suggests a specific protein fragment may serve as a marker for advanced chronic traumatic encephalopathy, though it does not detect early stages.

By Luca Fernandez ·

Illustration for: Researchers Find Higher Tau Levels in Advanced CTE Blood Samples
Illustration generated for this article, not a news photograph.

A new study published in JAMA on Friday reports that blood levels of a specific protein fragment are elevated in patients with advanced chronic traumatic encephalopathy. The research, conducted by scientists at Washington University in St. Louis, identifies a potential biomarker for a brain disease that currently can only be confirmed through autopsy.

The protein in question is tau, which normally supports neurons but becomes abnormal and tangles within nerve cells in Alzheimer’s disease. While tau abnormalities are known to occur in several brain disorders, the study focuses on a fragment called eMTBR-tau243. The team discovered this specific fragment while analyzing autopsy samples for Alzheimer’s markers.

During the initial analysis, researchers noticed a patient with high levels of eMTBR-tau243 who did not have Alzheimer’s but instead had advanced CTE. This finding prompted the team to test blood samples from a larger group of individuals who had been previously classified as having CTE. They compared these samples against those from healthy controls.

Chihiro Sato, an assistant professor of neurology at WashU and a coauthor of the study, stated that levels of eMTBR-tau243 were higher in people with advanced CTE compared to healthy individuals. However, the data showed that this biomarker could not reliably identify early-stage CTE. The results were also presented at a scientific meeting in Japan.

Dr. Rudolph Castellani, a neuropathologist at Northwestern University who was not involved in the research, described the finding as interesting but very preliminary. He emphasized that much larger studies are required to determine if there is a genuine connection between the protein levels and the disease. Sato agreed, noting that more research is needed to clarify the role of this tau fragment.

The difficulty in diagnosing CTE in living patients stems from the fact that symptoms such as mood swings and memory loss are common to other conditions. Currently, a definitive diagnosis requires examining the brain after death. Abnormal tau is present in multiple brain diseases, particularly in older adults where conditions often overlap, which complicates the isolation of specific markers for CTE.

The study analyzed blood stored from 11 people with CTE alongside healthy controls. The findings offer a tentative step toward biological markers for the disease, moving beyond symptom-based evaluation. The research team continues to investigate the relationship between tau fragments and traumatic brain injury.

More News · Report a business · Got a Story?

Get Breaking Blast in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.

Get Breaking Blast in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.